Alveus Therapeutics, Inc.
New Form D on file · 2026-01-14 · the record
What the record says
Trailing twelve months. 148 filings in Pharmaceuticals, totalled by week. The dot is this raise, $56.86M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Company officers on record
Gregory Parekh is named as Director on the Form D that Alveus Therapeutics, Inc. filed with the SEC on 14 January 2026, one of 8 people that filing names.
Ivan Gergel is named as Director on the Form D that Alveus Therapeutics, Inc. filed with the SEC on 14 January 2026, one of 8 people that filing names.
Garrett Ingram is named as Director on the Form D that Alveus Therapeutics, Inc. filed with the SEC on 14 January 2026, one of 8 people that filing names.
Carlo de Notaristefani is named as Director on the Form D that Alveus Therapeutics, Inc. filed with the SEC on 14 January 2026, one of 8 people that filing names.
Ameet Nathwani is named as Director on the Form D that Alveus Therapeutics, Inc. filed with the SEC on 14 January 2026, one of 8 people that filing names.
Raj Kannan is named as Executive Officer and Director on the Form D that Alveus Therapeutics, Inc. filed with the SEC on 14 January 2026, one of 8 people that filing names.
Jan Van de Bossche is named as Director on the Form D that Alveus Therapeutics, Inc. filed with the SEC on 14 January 2026, one of 8 people that filing names.
Claudio Nessi is named as Director on the Form D that Alveus Therapeutics, Inc. filed with the SEC on 14 January 2026, one of 8 people that filing names.
8 people named on the filing — 1 holding an executive role and 7 as directors only.
Named as of the 2026-01-14 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
- 8 people named on the filing — 1 holding an executive role and 7 as directors only.
No investor is drawn from a Form D — the form states how many invested and never who.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Alveus Therapeutics, Inc.
- Source Check — verify Raj Kannan's other claims against the registers that hold them.
- INVEST — size up this raise on the figures the filing states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Raj Kannan for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Alveus Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Alveus Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.